Synthesis of compounds 1-3
General Methods. The starting materials anthranilic acid, cyclohexanone, diamines, POCl 3 , phenol, NaI and solvents were commercially available, which were directly used as received without purification. The 1 H NMR and 13 C NMR spectra were taken on the Varian INOVA-600 or Varian INOVA-400 spectrometer, and the HRMS data were taken on the Shimadzu LCMS-IT-TOF. ChE activity was assessed using the Ellman's assay. 4 A Jasco V-530 double beam spectrophotometer connected to a HAAKE DC30 thermostating system (Thermo Haake, Germany) was used. Stock solutions of the tested compound (1-2 mM) were prepared in methanol and diluted in methanol. The assay solution consisted of a 0.1 M phosphate buffer, pH 8.0, with the addition of 340 M 5,5'-dithiobis(2-nitrobenzoic acid), 0.02 unit/mL human recombinant AChE or BuChE from human serum (SigmaAldrich, Italy), and 550 M substrate, i.e., acetylthiocholine iodide or butyrylthiocholine iodide, respectively (Sigma-Aldrich, Italy). Tested compounds were added to the assay solution at increasing concentrations and preincubated at 37°C with the enzyme for 20 min before the addition of substrate. The rate of absorbance increase at 412 nm was followed for 5 min. In parallel, blanks containing all components except the enzyme were prepared to account for the non enzymatic hydrolysis of the substrate.
The reaction rates were compared and the percent inhibition due to the presence of test compounds was calculated. Each concentration was analyzed in duplicate/triplicate. The percent inhibition of the enzyme activity due to the presence of inhibitor was calculated.
Inhibition plots were obtained for each compound by plotting the percent inhibition versus the logarithm of inhibitor concentration in the assay solution. The linear regression parameters were determined for each curve and the IC 50 extrapolated. All tested compounds showed a significant quenching of the thiofalvin T signal generated in the presence of preformed amyloid fibrils. The % quenching was determined and subtracted while calculating the inhibitory activity. Cultures were seeded into flasks containing supplemented medium and maintained at 37 ºC in a humidified atmosphere of 5% CO 2 and 95% air. Culture media were changed every 2 days. Cells were sub-cultured after partial digestion with 0.25% trypsin-EDTA.
Determination of the inhibitory effect on the A
For test, HepG2 cells were sub-cultured in 96-well plates at a seeding density of 1x10 5 cells per well. When the HepG2 cells reached 80% confluence, the medium was replaced with fresh medium containing 1-300 µM compounds (1-3 and tacrine used as reference) or 0.1% DMSO used as a vehicle control.
Measurement of cell viability
Cell viability was determined by quantitative colorimetric assay with 3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT). Briefly, 50 µL of the MTT labeling reagent, at a final concentration of 0.5 mg/mL, was added to each well at the end of the incubation period and the plate was placed in a humidified incubator at 37 ºC with 5% CO 2 and 95% air (v/v) for an additional 2 h period. Metabolically active cells convert the yellow MTT tetrazolium compound to a purple formazan product.
Then, the insoluble formazan was dissolved with DMSO; colorimetric determination of MTT reduction was measured in an ELISA microplate reader at 540 nm. Control cells treated with EMEM were taken as 100 % viability. within Discovery Studio, version 2.1, software package, using standard bond lengths and bond angles. With the CHARMm force field 8 and partial atomic charges, the molecular geometries of 1, 2 and 3 were energy-minimized using the adopted-based Newton-Raphson algorithm. Structures were considered fully optimized when the energy changes between iterations were less than 0.01 kcal/mol mol. 9 AutoDockTools (ADT; version 1.5.4) was used to add hydrogens and partial charges for proteins and ligands using Gasteiger charges. Flexible torsions in the ligands were assigned with the AutoTors module, and the acyclic dihedral angles were allowed to rotate freely. Trp286, Tyr124, Tyr337, Tyr72, Asp74, Thr75, Trp86, and Tyr341 receptor residues were selected to be flexible during docking simulation using the AutoTors module. The box center was defined and the docking box was displayed using ADT. The docking procedure was applied to the whole protein target, without imposing the binding site ("blind docking"). A grid box of 60 x 60 x 72 with grid points separated 1 Ǻ, was positioned at the middle of the protein (x = 116.546; y = 110.33; z = -134.181). Default parameters were used except num_modes, which was set to 40. The AutoDock Vina docking procedure used was previously validated. 11 The three-dimensional structure of hBuChE has been used (PDB ID: 4BDS). Proper bonds, bond orders, hybridization and charges were assigned using protein model tool in Discovery Studio, version 2.1, software package. CHARMm force field was applied using the receptor-ligand interactions tool in Discovery Studio. Docking calculations
Docking of compounds 1-3 into hAChE and hBuChE

S8
were performed following the same protocol described before for hAChE. All dockings were performed as blind dockings where a box of 66 x 66 x 70 Ǻ with grid points separated 1 Ǻ, was positioned at the middle of the protein (x=136.0; y=123.59; z=38.56). Default parameters were used except num_modes, which was set to 40. The lowest docking-energy conformation was considered as the most stable orientation.
Finally, the docking results generated were directly loaded into Discovery Studio, version 2.1. Two dimensional figures of the 1-3-enzymes interactions were groodmed using DS 2.1.
Docking analysis on hBuChE
Compounds 1-3 were modeled into the structure of hBuChE (PDB: 4BDS) and all the experiments were performed as blind dockings following the same computational protocol used for hAChE. The binding mode of compound 1 in the hAChE active site is not very different from the binding mode in the hBuChE active site. However, the orientations and conformations of compounds 2 and 3 in AChE were completely different from those in hBuChE. These ligands bind to hAChE with extended conformations whereas they bind to hBuChE with folded conformations ( Figure 7S ). The docking calculations of compounds 1, 2 and 3 at the active sites of hAChE and hBuChE revealed that the compounds bound to the hAChE enzyme with lower binding energy when compared with hBuChE enzyme. The energy gaps in hBuChE are approximately 0.3, 2.9 and 2.1 kcal/mol (for compounds 1, 2 and 3, respectively) higher than the calculated for the hAChE. The values of 2.9 and 2.1 Kcal/mol for the energetic penalties in compounds 2 and 3 can be, at least in part, the reason for why compound 2 is quite more selective than 3 for the inhibition of hAChE.
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